OUTCOMES OF PALLIATIVE TREAMENT FOR PERIAMPULLARY TUMORS BY BILIARY AND GASTROINTESTINAL DOUBLE BYPASS IN 2021-2023
Main Article Content
Abstract
Background: Periampullary tumors, which have a small proportion in gatrointestinal tumor, have a tendency to increase. Biliary and gastroenterostomy double bypass is palliative surgery, used commonly for patients found to be unresectable. However, there is inadequate evidence of its effectiveness in Vietnam. Therefore, this study was conducted more research into this particular solution. Objectives: (1) To determine the clinical and paraclinical characteristics in patient with periampullary tumors; (2) To evaluate the results of the palliative treatment for periampullary tumors by biliary and gastroenterostomy double bypass at Can Tho Central General Hospital and Can Tho General Hospital. Materials and methods: A prospective, cross-sectional study was conducted to assess the palliative treatment for 35 patients with periampullary tumors by biliary and gastroenterostomy double bypass at Can Tho Central General Hospital and Can Tho General Hospital in 2021-2023. Results: The average age of subjects was 61.4±10; the male:female ratio was approximately 1.2:1. The most common symptoms were jaundice (88.6%), abdominal pain (77.1%), weight loss (45.7%), pruritus (42.9%) and indigestion (31.4%). 85.3% of tumors were detected by CT scan. Warren biliary and gastric bypasses were performed in 74.3% and Roux-en-Y bypasses in 25.7%. Postoperative complications included wound infection accounting for 14.3%, delayed gastric emptying (17.1%), gastrointestinal bleeding (2.9%) and pancreatic fistula (2.9%). The postoperative time was 7.7±1.8 days. Conclusions: Biliary and gastric double bypass is a safe procedure but not curative, which reduces symptoms in patients with advanced periampullary tumors as a palliative treatment.
Article Details
Keywords
Periampullary tumor, biliary bypass, gastric bypass
References
2. Kang C. M., Lee J. H., Choi J. K., Hwang H. K., Chung J. U., et al. Can we recommend surgical treatment to the octogenarian with periampullary cancer?: National database analysis in South Korea. Eur J Cancer. 2021. 144, 81-90. DOI: 10.1016/j.ejca.2020.10.039.
3. Zinner M. J., Stanley W. A. Maingot's Abdominal Operations, 13e. McGraw-Hill Companies, Incorporated, 2019.
4. Evans D. B. What Makes a Pancreatic Cancer Resectable?. American Society of Clinical Oncology Educational Book. 2018. 38, 300-305, DOI: 10.1200/EDBK_200861
5. Tewari M. Surgery for Pancreatic and Periampullary Cancer: Principles and Practice. Springer. 2018. 29.
6. Abon J. C. R., Berberabe A. B. Current Epidemiology of Periampullary Malignancies in a Tertiary Referral Center in the Philippines: A Five-Year Review. Acta Medica Philippina. 2022. 56(14), https://doi.org/10.47895/amp.vi0.3952.
7. Syaiful R. A, Mazni Y., Amalia G., Rahadiani N., Toar Jean Maurice Lalisang T.J.M. Survival Analysis of Palliative Surgery of Advanced Stage Periampullary Cancer. Journal of the Pancreas. 2020. 21(1), 7-12.
8. Lee K. J., Yi S. W., Chung M. J., Park S. W., Song S. Y. et al. Serum CA19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Yonsei medical journal. 2013. 54(3), 643649, https://doi.org/10.3349/ymj.2013.54.3.643.
9. Nguyễn Anh Binh. Kết quả phẫu thuật nối tắt mật ruột trên bệnh nhân ung thư quanh bóng Vater. Đại học Y Dược Thành phố Hồ Chí Minh. 2017.
10. Đoàn Tiến Mỹ, Phạm Hữu Chí Thiện, Nguyễn Nguyễn Khôi, Nguyễn Tường Khoa, Đồng Ngọc Quang và cộng sự. Giá trị CA19-9 trong tiên đoán khả năng phẫu thuật triệt để ung thư đầu tụy tại Bệnh viện Chợ Rẫy. Hội nghị khoa học thường niên Bệnh viện Chợ Rẫy. 2020.
11. Lesurtel M., Dehni N., Tiret E., Parc R. Paye F. Palliative surgery for unresectable pancreatic and periampullary cancer: a reappraisal. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2006. 10(2), 286-291, https://doi.org/10.1016/j.gassur.2005.05.011.
12. Wellner U. F., Makowiec F., Bausch D., Höppner J., Sick O. et al. Locally advanced pancreatic head cancer: margin-positive resection or bypass?. ISRN surgery. 2012. 513241, https://doi.org/10.5402/2012/513241.